Post-TB lung disease: pathogenesis, host-directed therapies, and the C3HeB/FeJ model for pre-clinical advances. Ofori-Anyinam B, Nyiro B, Salgame P. Infect Immun 2026;94:e0052324.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ofori-Anyinam B, Nyiro B, Salgame P. Post-TB lung disease: pathogenesis, host-directed therapies, and the C3HeB/FeJ model for pre-clinical advances. Infect Immun 2026;94:e0052324.
PMID: 41661106